Preterm Birth and Risk of Health Service Use, Morbidity, and Medication Needs at 5 Years

Lindsay L Richter1, Ye Shen2, Sarka Lisonkova3

  • 1Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

JAMA Pediatrics
|September 8, 2025
PubMed

Insights

Children born preterm need more healthcare and face greater health challenges in their first five years, despite advances in neonatal care. This highlights the long-term impact of premature birth on health outcomes.

Area of Science:

  • Neonatal care and outcomes
  • Pediatric health services research
  • Population health

Background:

  • Neonatal intensive care has advanced significantly.
  • Premature birth continues to be a major cause of neonatal mortality and morbidity.
  • Long-term health outcomes for preterm infants require ongoing investigation.

Purpose of the Study:

  • To describe health service utilization, morbidity, and medication needs up to age 5 years in a contemporary cohort of children born preterm.
  • To quantify the association between gestational age at birth and health outcomes in early childhood.

Main Methods:

  • Population-based cohort study using linked administrative health and pharmacy data in British Columbia, Canada.
  • Included 448,819 children born between 2004 and 2014 with 5-year follow-up.
  • Analyzed gestational age at birth, health service use (hospitalizations, outpatient visits), morbidity diagnoses, and outpatient prescriptions.

Main Results:

  • Children born preterm had higher hospitalization rates and outpatient visits compared to those born at 39-41 weeks' gestational age.
  • Preterm birth was associated with increased risks of respiratory, endocrine, gastrointestinal, kidney, neurodevelopmental, and sleep disorders.
  • Preterm infants were more likely to receive outpatient antibiotics, bronchodilators, corticosteroids, diuretics, and thyroid hormones.

Conclusions:

  • Despite advances in neonatal care, children born preterm require more healthcare resources and experience greater health challenges in their first five years.
  • These findings underscore the critical need for continued support and monitoring of preterm infants beyond the neonatal period.
  • Gestational age at birth is a significant predictor of long-term health service use and morbidity in childhood.
Abstract

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188